The Cancer Target Discovery and Development (CTD 2 ) Network aims to use functional genomics to accelerate the translation of high-throughput and high-content genomic and small-molecule data towards use in precision oncology. As part of this goal, and to share its conclusions with the research community, the Network developed the 'CTD 2
Introduction
The current Cancer Target Discovery and Development (CTD 2 ) initiative is a collaborative group of 13 different research teams, or Centers, organized under the auspices of the National Cancer Institute's Office of Cancer Genomics. It aims to functionally validate discoveries from large-scale adult and pediatric cancer-genome characterization initiatives, and advance them towards use in precision medicine. CTD 2 Centers use high-throughput experimental and bioinformatic approaches to mine the data and find alterations that potentially influence tumor biology. The Network characterizes the functional roles of candidate alterations in cancers, and identifies novel approaches that target causative alterations through their associated biological pathways. Through the individual and synergistic efforts of the Centers and broad sharing of data with the research community, CTD 2 contributes to understanding the mechanisms of cancer initiation, maintenance, and progression, and supports the accelerated development of clinically useful markers, targets, and therapeutics. CTD 2 is a 'community resource project' [https://www.
genome.gov/pages/research/wellcomereport0303.pdf] meaning all data are openly available to the scientific community and can be accessed without restrictions. The Network as a whole applies a wide range of investigational approaches, including computational biology, genome-wide loss-of-function or gain-of-function in vitro and ex vivo screening, highthroughput small-molecule screening, and protein-protein interaction analysis, among others. The web-based open-access CTD 2 Data Portal [https://ocg.cancer.gov/programs/ ctd2/data-portal/] is the primary outlet by which the Network shares these diverse datasets (positive and negative results generated as part of each Center's research) and the associated project descriptions and methodologies.
Although the Network has a dedicated process to harmonize the data, a certain level of bioinformatics expertise is needed to use the data in the Data Portal to their fullest potential. The data in the Portal are generated with technologyrelevant controls and undergo quality assessment, but have not been independently validated [https://ocg.cancer.gov/ sites/default/files/CTD2CaveatEmptor_final.pdf]. Therefore, researchers who are using the data must further validate findings in order to determine the significance and strength of a particular result. Network results are shared through published manuscripts, which contain data and related information. However, these data are not always provided in an easily digestible format for all types of researcher. Such publications concentrate on the biological relevance of a few findings the authors find interesting, although in largescale high-throughput experiments, there may be many other positive findings. The CTD 2 Dashboard [https://ctd2-dashboard.nci.nih.
gov/] addresses these data-access and usability challenges and fills the need for a searchable and browsable web interface that assembles concisely summarized results, connects them with subsequent evidence that reinforces or builds upon the original finding, and conveys the extent to which the results have been functionally validated. The Dashboard was developed to address the need of the community to find data generated by CTD 2 , and to adhere to the FAIR (findable, accessible, interope rable and reusable) principles (1). The Dashboard was designed to allow easy navigation and use by a range of scientists, including both computationalists and non-computational cancer experts.
Database structure and organization
The Dashboard concept harboring LYN mutations'. The italicized words in this example highlight the building blocks of an observation, namely the subjects, and are hyperlinked in the Dashboard interface. The bold text 'sensitive' summarizes a piece of evidence that defines the result (enrichment among sensitive cell lines, in this case). Additionally, observations are linked to background information and other evidence, i.e., assay-specific data which corroborate the observation statement. For instance, for the example observation shown above, relevant evidence could include the false discovery rate, an enrichment plot and the number of cell lines used. These CTD 2 Dashboard principles are illustrated in more detail in subsequent sections.
Subjects-focus of the experiments
As one mission of the CTD 2 Network is to discover and develop new therapeutic hypotheses, we expected that cancer-relevant genes and the proteins they encode (e.g., oncoproteins) would need to be explicit in our model. In addition, perturbation reagents such as small molecules or shRNAs, and certain common experimental systems, such as named cell lines and mouse models, were also included. 'Subjects' are the focus of experiments and are categorized into classes, such as genes, proteins, perturbagens, and model systems. A critical first decision in conceptualizing the CTD 2 Dashboard was to decide which entities would be considered well-defined classes for the purposes of cross-linking different types of evidence. Together, these subject classes form the core knowledge skeleton of the CTD 2 Dashboard, allowing researchers from multiple Centers to connect observations and other evidence to the same abstract entity, even when studied in separate laboratories. These subject names are made consistent through vocabulary control and synonym reconciliation, ideally via an external authority (e.g., gene names and synonyms from HUGO Gene Nomenclature Committee database). In some cases, such as for cell lines and mouse models, no suitable external authority was already available, so the CTD 2 Dashboard development team curated and reconciled synonyms for these subjects. This construction allows the knowledge built around a subject to be greater than the sum of the individual contributions. Subject choices permit extensive connection to structured resources outside of the CTD 2 Dashboard for additional external data and metadata. Importantly, each subject class warrants connection to different types of metadata and resources. For example, genes and proteins are described with controlled names and identifiers, and the CTD 2 Dashboard links out to other resources, including Entrez and UniProt, which provide additional summary information, genomic context, functional annotations, macromolecule sequences, and references. Genes are also linked to their monograph pages in the cBioPortal (3, 4) , which provides frequencies of alteration of the gene in different cancer types, as well as mutation and expressionlevel information in collections of samples. Similarly, small-molecule probes and drugs can connect to sources of outside information, as many public databases of such entities are available (5-7). At present, small-molecule monographs in the Dashboard link to their corresponding entries in PubChem (7), which provide summaries of activity and mechanism of action, where available, along with chemical information and descriptors, structure representations, and links to bioactivity assays using the compound. New versions of the Dashboard will add links to other resources, such as the BioAssay Research Database (8) and the Cancer Therapeutics Response Portal (9-11), through which additional information about compound activity, including in cancer cell models, can be accessed. By linking to external data about subjects whenever possible, we enrich the CTD 2 Dashboard with content beyond that generated explicitly by the CTD 2 Network.
Roles-functions assigned to subjects based on supporting data
Due to the diversity of experiments done by CTD 2 Network
Centers and the inherent characteristic of subjects to have multiple possible biological functions, subject classes alone are not sufficient to provide all the contextual information needed to understand the relationships between subjects. Contextual architecture is independent of subject matter
The fundamental structure of the CTD 2 Dashboard architecture is not coupled to cancer targets, cancer biology, or even biology. Indeed, any system of controlled subject names could serve as a knowledge skeleton for attaching evidence. We have not fully explored alternative knowledge domains beyond the conceptual stage, but certainly encourage others to do so. Controlled-name subjects with any entity-relational framework could be coupled with evidence classes used in the current CTD 2 Dashboard: labels, numeric values, URLs, images, and attached files. In this sense, the CTD 2 Dashboard serves as a way to link an 'operating system' of file types with each member subject of a given class. In other words, the Dashboard does not need to understand the contents of the evidence being linked, only the format in which that evidence is being presented.
User interface
The end-user-facing web application is constructed in two layers. The back-end is implemented as a series of RESTful web services based on the Spring framework, a widely used application framework and inversion-of-control container for the Java platform Researchers who visit the CTD 2 Dashboard to investigate a specific gene or compound will find the Search function to be the most expedient method for locating relevant data. CTD 2 Dashboard data are indexed against subject terms and can be queried using the search box located in the top menu bar of the CTD 2 Dashboard. For instance, searching for a full or partial gene symbol will generate a list of all matching genes along with a count of the observations involving each gene; each count is hyperlinked to a detailed list of the relevant observations. In addition to search, data can be explored via several browsing options.
• Subject-based browsing: Exploration of CTD 2 Dashboard entries can be initiated from a summary view. The CTD 2 Dashboard offers three "Browse" pages focusing on genes, compounds, and cancer types. Each page provides a list of biological entities prioritized according to the number, breadth, and level of validation of the observations involving those entities. For example, the 'Biomarkers, Targets, Genes & Proteins' browse page focuses on genes and lists roles and observations associated with each subject (Figure 2 ). Users can download this table as an Excel file using the function called "Export as Spreadsheet".
• Submission-based browsing: The 'Centers' link at the site's top navigation bar leads to a page that lists all the CTD 2 Network Centers. From that list, users can access all data submissions produced by a Center and drill down to the observation data in each submission. There is also a link which allows the user to easily and directly download the entire submission source data package.
• Story-based browsing: Research findings that have been explored in detail are featured prominently on the homepage of the CTD 2 Dashboard in the form of stories. The aim of stories is to distill the essential elements of reported results, including integration of many experiments at different levels of evidence, at a level of detail that is appropriate for a general scientific audience.
Search and browse operations ultimately result in a list of entry points to detailed information about observations and subjects. For instance, clicking on any gene symbol under the 'Name' column in the gene-browser list leads to a gene profile page (Figure 3) where the top portion contains key gene descriptors and links to relevant annotations and resources, and the bottom portion lists the observations generated by the Centers involving that gene. As with the browse feature, users can download this entire table as an Excel file using the button 'Export to Spreadsheet'. Similarly, clicking on the 'details' link of any observation brings up a page (Figure 4 ) describing the observation attributes, including:
• a short summary of the related investigational finding (i.e., the observation summary); • the biological entities (genes, compounds, cell lines, etc.) involved in the study and their specific roles; • description of the submission, submission date, and a link to download all the data (evidence) associated with that submission; • experimentally and computationally derived evidence supporting the reported finding.
Gene Cart
Many CTD 2 Dashboard pages contain green 'þ' icons adjacent to gene symbols (see Figures 3 and 4) . During Dashboard data exploration, users can click on these icons to incrementally compile a list of genes of interest. This list can be accessed through the 'Gene Cart' link available in CTD 2 Dashboard's navigation menu (Figure 5a ). From there, users are able to edit the contents of the list and to query the Cellular Networks Knowledge Base (CNKB) (12) repository of molecular interaction networks to retrieve interactions involving the genes in the Gene Cart (Figure 5b and c) . CNKB (12) is a database of protein and gene interactions maintained at Columbia University. It comprises curated pathway collections and cancer tissuespecific regulatory and signaling networks derived computationally through the analysis of large gene-expression datasets (13) such as those generated by The Cancer Genome Atlas, and also predicted or measured proteinprotein interactions (14, 15) . The ability to interrogate CNKB and to explore the interactions involving key tumor regulators can help users better contextualize and interpret Dashboard observations. For instance, if an shRNA screen reduces the viability of a tumor cell line, looking at the interaction network involving the shRNA targets may reveal the underlying mechanism of action by identifying genes regulated by these targets.
Discussion
As content continues to grow and submitters continue to find creative uses for the Dashboard as a data-sharing platform, the CTD 2 Dashboard team will continue to improve the database and interface (Figure 1 ). Our current major undertaking to improve CTD 2 Dashboard functionality is creating a web-based submission-generation system that uses standardized formats, thereby reducing the time and complexity of the submission process by automating data import and validation. Plans to improve the user experience and further enrich the content include linking to additional outside resources that the Network selects as useful. For example, on the gene-entry pages, hyperlinks will point users Conflict of interest. None declared. 
